Search

Your search keyword '"Joseph, Sacco"' showing total 30 results

Search Constraints

Start Over You searched for: Author "Joseph, Sacco" Remove constraint Author: "Joseph, Sacco"
30 results on '"Joseph, Sacco"'

Search Results

1. A case of immunotherapy-induced thyroiditis

2. Protocol for the EACH trial: a multicentre phase II study evaluating the safety and antitumour activity of the combination of avelumab, an anti-PD-L1 agent, and cetuximab, as any line treatment for patients with recurrent/metastatic head and neck squamous cell cancer (HNSCC) in the UK

3. Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanoma

4. SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia—a phase II randomised control trial study protocol

5. Two distinct clinical patterns of checkpoint inhibitor-induced thyroid dysfunction

6. 506 IGNYTE: an open-label, multicenter, phase 1/2 (Ph 1/2) clinical trial of RP1 ± nivolumab in patients with advanced solid tumors

7. 538 Updated survival of patients with previously treated metastatic uveal melanoma who received tebentafusp

8. 507 A phase 1 clinical trial of RP2, an enhanced potency oncolytic HSV expressing an anti-CTLA-4 antibody, as a single agent and combined with nivolumab in patients with advanced solid tumors

9. 421 Initial results of a phase 1 trial of RP2, a first in class, enhanced potency, anti-CTLA-4 antibody expressing, oncolytic HSV as single agent and combined with nivolumab in patients with solid tumors

10. Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: the WISTERIA trial protocol

13. 610 Immune biomarker analysis of RP1 in combination with nivolumab in patients with advanced solid tumors

14. 611 Biodistribution and shedding analysis following treatment with RP1 oncolytic immunotherapy in the skin cancer patients from the IGNYTE clinical trial

15. Initial Invasive or Conservative Strategy for Stable Coronary Disease

16. Evolocumab in HIV-Infected Patients With Dyslipidemia

17. Long-term effects of evolocumab in participants with HIV and dyslipidemia: results from the open-label extension period

18. Health status after invasive or conservative care in coronary and advanced kidney disease

19. Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study

21. Relation between achieved heart rate and outcomes in patients with atrial fibrillation (from the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] Study)

22. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: The Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial

23. Resveratrol induces Fas signalling-independent apoptosis in THP-1 human monocytic leukaemia cells

24. Pertussis Toxin–Induced Lung Edema

25. [Untitled]

26. The effects of the Palliative Medicine Consultation on the DNR status of African Americans in a safety-net hospital

27. Palliative care consultation teams cut hospital costs for Medicaid beneficiaries

28. Relation of initial resting ventricular rate to the ability to achieve and maintain normal sinus rhythm in patients with atrial fibrillation

29. Department of Veterans Affairs Cooperative Studies Program Clinical Trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction: primary results of the CHAMP study

30. Mismanaged journalism Responsible reporting in Peril at The New York Times

Catalog

Books, media, physical & digital resources